Silverarc Capital Management, LLC Lava Therapeutics Nv Transaction History

Silverarc Capital Management, LLC

  • $402 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$1.59 - $3.97 $472,978 - $1.18 Million
-297,471 Reduced 67.95%
140,291 $232,000
Q4 2022

Feb 14, 2023
SELL
$3.37 - $7.31 $583,168 - $1.26 Million
-173,047 Reduced 28.33%
437,762 $1.53 Million
Q3 2022

Oct 28, 2022
BUY
$2.34 - $4.75 $1.43 Million - $2.9 Million
610,809 New
610,809 $2.79 Million

Others Institutions Holding LVTX

# of Institutions
28
Shares Held
3.61M
Call Options Held
32.9K
Put Options Held
500
View Full List

About LAVA Therapeutics NV

LVTX Quotes by TradingView
  • Ticker LVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,797,700
  • Market Cap $26.8M
  • Description
  • LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer...
More about LVTX
Track This Portfolio

Track Silverarc Capital Management, LLC Portfolio

Follow Silverarc Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silverarc Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email